INTERNATIONAL PATENT: G2GBIO, INC., 주식회사 지투지바이오 FILES APPLICATION FOR "LONG-ACTING INJECTABLE COMPOSITION COMPRISING SUSTAINED-RELEASE MICROSPHERES CONTAINING BREXPIPRAZO"

GENEVA, Sept. 30 -- G2GBIO, INC. (21 Uiryodanji-gil, Osong-eup, Heungdeok-gu,Cheongju-si,Chungcheongbuk-do 28161), 주식회사 지투지바이오 (충청북도청주시흥덕구 오송읍 의료단지길 21) filed a patent application (PCT/KR2025/003675) for "LONG-ACTING INJECTABLE COMPOSITION COMPRISING SUSTAINED-RELEASE MICROSPHERES CONTAINING BREXPIPRAZO" on Mar 21, 2025. With publication no. WO/2025/198371, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is m...